Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Horn

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Advances in Therapy|November 8, 2017
The Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Chronic Idiopathic Constipation (BURDEN-CIC) Study: Results of an Online QuestionnaireLucinda A Harris, John Horn, Michele Kissous-Hunt, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 19, 2024
Evaluation of an electronic health record Drug Interaction Customization Editor (DICE)Andrew Romero, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, et al.
Advances in Therapy|June 28, 2018
Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online QuestionnaireEamonn M M Quigley, John Horn, Michele Kissous-Hunt, et al.
Drug Safety|October 12, 2022
Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"Daniel C Malone, Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, et al.
Journal of Medical Internet Research|January 6, 2019
Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based SurveyAmy J Grizzle, John Horn, Carol Collins, et al.
Drug Safety|July 14, 2022
A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, John Horn, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|February 27, 2015
Drug-drug interaction data source survey and linkingSerkan Ayvaz, Qian Zhu, Harry Hochheiser, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 26, 2007
Analysis of antigen-specific antibodies and their isotypes in experimental malariaHenri C van der Heyde, James M Burns, William P Weidanz, et al.
Polymer Reviews (Philadelphia, Pa.)|May 7, 2013
Porous Shape Memory PolymersKeith Hearon, Pooja Singhal, John Horn, et al.
The Annals of Pharmacotherapy|May 27, 2023
Reply: Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)Daniel C Malone, Ainhoa Gómez-Lumbreras, Richard D Boyce, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Advances in Therapy|November 8, 2017
The Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Chronic Idiopathic Constipation (BURDEN-CIC) Study: Results of an Online QuestionnaireLucinda A Harris, John Horn, Michele Kissous-Hunt, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 19, 2024
Evaluation of an electronic health record Drug Interaction Customization Editor (DICE)Andrew Romero, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, et al.
Advances in Therapy|June 28, 2018
Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online QuestionnaireEamonn M M Quigley, John Horn, Michele Kissous-Hunt, et al.
Drug Safety|October 12, 2022
Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"Daniel C Malone, Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, et al.
Journal of Medical Internet Research|January 6, 2019
Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based SurveyAmy J Grizzle, John Horn, Carol Collins, et al.
Drug Safety|July 14, 2022
A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, John Horn, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|February 27, 2015
Drug-drug interaction data source survey and linkingSerkan Ayvaz, Qian Zhu, Harry Hochheiser, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 26, 2007
Analysis of antigen-specific antibodies and their isotypes in experimental malariaHenri C van der Heyde, James M Burns, William P Weidanz, et al.
Polymer Reviews (Philadelphia, Pa.)|May 7, 2013
Porous Shape Memory PolymersKeith Hearon, Pooja Singhal, John Horn, et al.
The Annals of Pharmacotherapy|May 27, 2023
Reply: Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)Daniel C Malone, Ainhoa Gómez-Lumbreras, Richard D Boyce, et al.
Pageof 4